FSM Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
FSM Wealth Advisors's VRTX Position: Q2 2026 in Review
FSM Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 7.6% in Q2 2026, buying an estimated $29.3K and bringing the position to 930 shares worth $462K. The position accounts for 0.05% of the portfolio, ranked #196.
FSM Wealth Advisors first reported a position in VRTX in Q3 2024 and has held it in 6 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- FSM Wealth Advisors held 930 shares of Vertex Pharmaceuticals worth $462K as of Q2 2026.
- FSM Wealth Advisors bought 66 Vertex Pharmaceuticals shares in Q2 2026, an estimated $29.3K.
- Vertex Pharmaceuticals made up 0.05% of FSM Wealth Advisors's portfolio in Q2 2026, its #196 holding.
- FSM Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.